Noninvasive Transcutaneous Glucometer Development
Launched by INLIGHT SOLUTIONS · Jul 21, 2010
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
The feasibility of measuring blood glucose concentration in patients with diabetes mellitus using near infrared (NIR) spectroscopy and multivariate data analysis techniques has been established using general purpose, scientific-grade infrared spectrophotometers under the 90-049 UNM HRRC protocol. Now that the concept of painless, bloodless, and reagent-less clinical laboratory tests has been shown to be viable, the challenge is to bring this technology to the patients who need it. We must develop a device that is portable, affordable, and rugged - all while improving accuracy. We must also ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Healthy
- • Type I diabetics
- • Type II diabetics
- • Impaired glucose tolerance
- Exclusion Criteria:
- • Minor status (\<18 years of age)
- • Pregnant
About Inlight Solutions
Inlight Solutions is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a commitment to enhancing patient outcomes, Inlight Solutions specializes in designing, managing, and executing clinical trials across various therapeutic areas. The organization leverages cutting-edge technologies and a patient-centric approach to streamline trial processes and ensure compliance with regulatory standards. Inlight Solutions collaborates with healthcare professionals, institutions, and industry partners to facilitate the successful translation of scientific discoveries into effective treatments, ultimately contributing to the improvement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albuquerque, New Mexico, United States
Patients applied
Trial Officials
Mark Rohrscheib, M.D.
Principal Investigator
UNMHSC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials